Ahmad Fahmy, OD, FAAO, DIPL, ABBO, kicks off the second annual Twin Cities Ocular Surface Disease Symposium with an introduction to the 2019 conference.
Startup S5G Therapeutics aims to move ubiquinol technology from the laboratory toward treatments for dry eye, Fuchs dystrophy, and other corneal conditions.